Protalix Bio submits Type A meeting request to FDA for PRX-102 in Fabry disease
August 02 2021 - 07:07AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Mar 2023 to Mar 2024